BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6191861)

  • 1. Diversity of immunological phenotypes of lymphoblastic lymphoma.
    Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
    Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of 3A1 monoclonal antibody in the diagnosis of T-cell acute lymphoblastic leukemia.
    Lopez M; De Rossi G; Bonomo G; Napolitano M; Pasqualetti D; Guglielmi C; Annino L; Pandolfi F
    Diagn Immunol; 1985; 3(1):11-4. PubMed ID: 3873317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic complexity of lymphoblastic lymphoma.
    Grogan T; Spier C; Wirt DP; Hicks MJ; Paquin M; Hutter J; Miller T; Rangel C; Richter L; Jones S
    Diagn Immunol; 1986; 4(2):81-8. PubMed ID: 3086016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypic analysis of human T-cell lymphoma with reference to cell differentiation and morphological classification].
    Feller AC
    Veroff Pathol; 1989; 131():1-175. PubMed ID: 2694674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of leukocyte common antigen in lymphoblastic lymphoma and small noncleaved undifferentiated non-Burkitt's lymphoma: an immunohistochemical study.
    Van Eyken P; De Wolf-Peeters C; Van den Oord J; Tricot G; Desmet V
    J Pathol; 1987 Apr; 151(4):257-61. PubMed ID: 2953875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemias and lymphomas of thymic differentiation.
    Borowitz MJ; Falletta JM
    Clin Lab Med; 1988 Mar; 8(1):119-34. PubMed ID: 2896085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoperoxidase study of 18 malignant lymphoblastic lymphomas (LMLbl) in children].
    Caillaud JM; Sastre X; Carlu C; Patte C
    Ann Pathol; 1986; 6(3):183-91. PubMed ID: 3535818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Setoya T; Takenaka T; Ishihara K; Watanabe S; Hoshino H; Miwa M; Kinoshita M; Okabe S; Fukushima N; Inada N
    Jpn J Clin Oncol; 1983; 13 Suppl 2():165-87. PubMed ID: 6603526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological diagnosis of the antigenic markers of acute lymphatic leukaemias and non-Hodgkin lymphomas in childhood (author's transl)].
    Thränhardt H; Zintl F; Plenert W
    Arch Geschwulstforsch; 1978; 48(4):289-300. PubMed ID: 308796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
    Pituch-Noworolska A; Miezyński W
    Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and analysis of the clinical course of T-phenotype acute lymphoblastic leukemia.
    Babusíková O; Hrivnáková A; Cáp J; Ujházy P
    Neoplasma; 1988; 35(6):683-90. PubMed ID: 2975765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.